These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15262489)

  • 1. Nonspecific antiviral immunity by formalin-fixed Coxiella burnetii is enhanced in the absence of nitric oxide.
    Rolph MS; Mahalingam S; Cowden WB
    Virology; 2004 Aug; 326(1):1-5. PubMed ID: 15262489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
    Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
    Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
    Rolph MS; Ramshaw IA; Rockett KA; Ruby J; Cowden WB
    Virology; 1996 Mar; 217(2):470-7. PubMed ID: 8610438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced production of nitric oxide and sensitivity of alveolar macrophages derived from mice with different sensitivity to Coxiella burnetii.
    Yoshiie K; Matayoshi S; Fujimura T; Maeno N; Oda H
    Acta Virol; 1999 Oct; 43(5):273-8. PubMed ID: 10757226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR2 is necessary to inflammatory response in Coxiella burnetii infection.
    Meghari S; Honstettre A; Lepidi H; Ryffel B; Raoult D; Mege JL
    Ann N Y Acad Sci; 2005 Dec; 1063():161-6. PubMed ID: 16481508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection.
    Meghari S; Berruyer C; Lepidi H; Galland F; Naquet P; Mege JL
    Eur J Immunol; 2007 Jan; 37(1):24-32. PubMed ID: 17163446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.
    Brennan RE; Russell K; Zhang G; Samuel JE
    Infect Immun; 2004 Nov; 72(11):6666-75. PubMed ID: 15501800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between LPS-induced NO production and IDO activity in mouse peritoneal cells in the presence of activated Valpha14 NKT cells.
    Ohtaki H; Ito H; Ando K; Ishikawa T; Hoshi M; Tanaka R; Osawa Y; Yokochi T; Moriwaki H; Saito K; Seishima M
    Biochem Biophys Res Commun; 2009 Nov; 389(2):229-34. PubMed ID: 19715679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
    Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
    Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Histocompatibility Complex Class II-Restricted, CD4
    Ledbetter L; Cherla R; Chambers C; Zhang Y; Mitchell WJ; Zhang G
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31792078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.
    Fernandes TD; Cunha LD; Ribeiro JM; Massis LM; Lima-Junior DS; Newton HJ; Zamboni DS
    Infect Immun; 2016 Sep; 84(9):2439-48. PubMed ID: 27297388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii.
    Ganesan S; Roy CR
    PLoS Pathog; 2019 Aug; 15(8):e1007955. PubMed ID: 31461509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine.
    Guatteo R; Seegers H; Joly A; Beaudeau F
    Vaccine; 2008 Aug; 26(34):4320-8. PubMed ID: 18586060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC; Peacock MG; Race RE
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.
    Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC
    Cancer Res; 2004 Oct; 64(19):6849-53. PubMed ID: 15466171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses.
    Landgraf RG; Russo M; Jancar S
    Eur J Pharmacol; 2005 Aug; 518(2-3):212-20. PubMed ID: 16023634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of non-specific antibacterial activity of the peritoneal cells of mice induced with Coxiella burnetii antigen.
    Tokarevich NK; Freidlin IS; Kuzina VA; Dimitrieva GM; Kaftyreva LA; Artyomenko NK
    Acta Virol; 1992 Jan; 36(1):25-31. PubMed ID: 1350168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for the CD28 molecule in the control of Coxiella burnetii infection.
    Honstettre A; Meghari S; Nunès JA; Lepidi H; Raoult D; Olive D; Mege JL
    Infect Immun; 2006 Mar; 74(3):1800-8. PubMed ID: 16495554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.